Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/01/2021 11 0
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Theaflavin 3,3'-digallate Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021 3 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 8 0
Calpain inhibitor II Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 4 0
Calpain inhibitor XII Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 5 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 20 10
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Robustaflavone Potential treatment - theoretical effect Natural product Antiviral Feb/04/2021 2 0